Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by jimmyhorizonon Jun 15, 2022 7:10am
118 Views
Post# 34757282

RE:The prc PARTNERS interview

RE:The prc PARTNERS interview
forhandlaren wrote: prc PARTNERS is a shareholder as everyone else? Or maybe not!

I think they were given information pre-deal based on:
- the interview is very polished - I like it, but very hard to accomplish in one day
- getting hold of three key management resources during the ongoing conference?
- the reference to share price close Friday June 10th on investment highlights

That raises the question of they bought shares based on in-the-know pre-deal?!

It also suggest that the close relationship indicates that the numbers published by prc PARTNERS pre- and post-deal are related to the real world. Could of course be debated.Was it $20M upfront?



no the question is not whether someone bought in the know before the deal, but sold in the know after the hype.

<< Previous
Bullboard Posts
Next >>